Broker Ratings

Elevance Health, Inc. Share Price Target ‘$516.65’, now 34.0% Upside Potential

Elevance Health, Inc. which can be found using ticker (ELV) have now 19 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $625.00 and $458.00 suggesting an average analyst share price target price of $516.65. (at the time of writing). Given that the stocks previous close was at $385.56 and the analysts are correct then there would likely be a percentage uptick in value of 34.0%. It’s also worth noting that there is a 50 day moving average of $428.92 and the 200 day moving average is $503.23. The company has a market capitalization of 89.42B. The stock price is currently at: $378.39 USD

The potential market cap would be $119,823,782,515 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 13.77, revenue per share of $747.41 and a 5.84% return on assets.

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. Carelon Services offers a broad array of healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Elevance Health, Inc. (ELV) Stock Analysis: A Strong Buy with 8% Upside Potential

    Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, stands as a formidable player in the U.S. healthcare sector with a significant market capitalization of $78.54 billion.

    Elevance Health, Inc. (ELV) Stock Analysis: A Promising Healthcare Play with a 6.4% Upside Potential

    Elevance Health, Inc. (NYSE: ELV), a prominent player in the U.S. healthcare sector, is drawing attention from investors due to its robust market positioning and potential for further growth. With

    Elevance Health, Inc. (ELV) Stock Analysis: A Healthcare Giant with a 3.11% Potential Upside

    Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, has been making significant strides in the sector with its comprehensive range of health benefits and services.

    Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 16.27% Upside Potential for Investors

    Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, is capturing investor attention with its compelling growth trajectory and robust market position. With a market capitalization

    Elevance Health, Inc. (ELV) Investor Outlook: Analyzing a 16.27% Potential Upside in the Healthcare Plans Sector

    Elevance Health, Inc. (NYSE: ELV), a dominant player in the healthcare plans industry, offers a compelling case for investors seeking growth and income opportunities in the healthcare sector. With a

    Elevance Health, Inc. (ELV) Stock Analysis: Navigating a 18.08% Potential Upside in the Healthcare Sector

    Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare plans industry, is capturing investor attention with its promising potential upside of 18.08%. This established health benefits company, formerly known

      Search

      Search